Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines
Open Access
- 5 February 2007
- Vol. 109 (5) , 957-965
- https://doi.org/10.1002/cncr.22479
Abstract
BACKGROUND.: Approximately 30% to 40% of all patients with osteosarcomas ultimately experience recurrence. The study investigated the hypothesis that the resistance of osteosarcoma to chemotherapy may be related to the expression of a pregnane xenobiotic receptor (PXR) variant protein and its role as the major inducer of P450 3A4 in these tumors.METHODS.: Polymerase chain reaction (PCR) and Western blot analysis were used to determine PXR mRNA and protein expression, respectively. Real‐time PCR and CYP3A catalytic activity using 7‐benzyl‐trifluoromethyl coumarin (BFC) as the probe substrate were used to measure the induction of P450 3A4 or MDR1. siRNA transfections were performed for PXR and cytotoxicity determined by a colorimetric based assay or Annexin v‐Fitc staining.RESULTS.: Differences were observed in the molecular size of the PXR protein expressed in sarcoma cell lines when compared with the wildtype PXR expressed in normal liver, kidney, or small intestine. A polyclonal PXR antibody raised against the N‐terminus of the wildtype PXR did not detect PXR expressed in these sarcoma cell lines. In the osteosarcoma cell lines, etoposide and doxorubicin were better inducers of P450 3A4 and MDR1 than rifampin. siRNA against PXR down‐regulated P450 3A4 expression only in the osteosarcoma cell line. Cytotoxicity assays showed that the resistance of the osteosarcoma cell lines to etoposide correlated with PXR protein expression levels and activation of P450 3A4 and could be prevented by ketoconazole.CONCLUSION.: The results suggest that PXR plays a critical role in the regulation of P450 3A4 expression in osteosarcoma and that its expression and activation in these tumors may influence the effect of chemotherapeutic agents on the induction of target genes implicated in drug resistance. Cancer 2007. © 2007 American Cancer Society.Keywords
This publication has 39 references indexed in Scilit:
- Biodegradable polyphosphoester micelles for gene deliveryJournal of Pharmaceutical Sciences, 2004
- FUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONDrug Metabolism and Disposition, 2004
- Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXRJournal of Biological Chemistry, 2003
- Regulation of CYP3A5 by Glucocorticoids and Cigarette Smoke in Human Lung-Derived CellsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Nuclear expression of Y‐box‐binding protein‐1 correlates with P‐glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcomaThe Journal of Pathology, 2003
- Humanized xenobiotic response in mice expressing nuclear receptor SXRNature, 2000
- Evidence for the Presence of a Functional Pregnane X Receptor Response Element in the CYP3A7 Promoter GeneBiochemical and Biophysical Research Communications, 1999
- SXR, a novel steroid and xenobioticsensing nuclear receptorGenes & Development, 1998
- Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sectionsNature Medicine, 1995
- Use of a trypan blue assay to measure the deoxyribonucleic acid content and radioactive labeling of viable cells.Journal of Histochemistry & Cytochemistry, 1980